Proteolysis Targeting Chimera (PROTAC) Linkerology Enhances the CDK-Degradation Selectivity Profile of a Multi-CDK Inhibitor: Discovery of Potent, Anti-Leukemic CDK9 Degraders.
The degradation efficiency of a PROTACbivalent compounds that link together a ligand for a protein of interest with a ligand for an E3 ligaseis governed, in part, by the length and flexibility of its linker ("linkerology"), as well as the accessibility of ubiquitinatable surface lysines. Based on the prior serendipit...